Eltrombopag Olamine API
| Name of Product | Eltrombopag Olamine API |
|---|---|
| CAS No | 496775‑62‑3 |
| Therapeutic use:- | Thrombopoietin receptor (TpoR) agonist; used to treat thrombocytopenia such as chronic immune thrombocytopenia and aplastic anemia |
| Form:- | API Powder |
| Grade | IH |
| Status | Regular |
Product Overview
Eltrombopag olamine API is a small chemical that activates thrombopoietin receptors.
It increases platelet synthesis in the bone marrow.
Indicated for the treatment of thrombocytopenia, especially in severe aplastic anemia, chronic hepatitis C, and chronic immune thrombocytopenia.
Therapeutic Applications
Control Chronic Immune Thrombocytopenia. This helps patients with low platelet counts and lowers bleeding risks.
Tends to support antiviral therapy by maintaining platelet levels.
Treating severe aplastic anemia, which induces hematopoiesis in patients with limited treatment options.
Eltrombopag is being studied for potential use in chemotherapy-induced thrombocytopenia.
Specification Parameters
Packaging & Storage
Eltrombopag Olamine will come in aluminium foil bags, sterile vials, and HDPE bottles.
Has to be stored at a cool temperature of 2–8 °C. Protect from light and moisture.
Why Choose Us
Choosing us guarantees top-quality products made under strict GMP standards.
There is a well-organised logistics network ensuring timely delivery worldwide.
Offer customised packaging support along with technical documentation and regulatory provisions.